Biblio

Found 16 results
Filters: Keyword is Disease Models, Animal  [Clear All Filters]
2017
Lai Y-Y, Cheng Y-H, Hsieh K-C, Nguyen D, Chew K-T, Ramanathan L, Siegel JM.  2017.  Motor hyperactivity of the iron-deficient rat - an animal model of restless legs syndrome.. Movement Disorders. 32(12):1687-1693.
2016
Northrop NA, Halpin LE, Yamamoto BK.  2016.  Peripheral ammonia and blood brain barrier structure and function after methamphetamine.. Neuropharmacology. 107:18-26.
2013
John J, Thannickal TC, McGregor R, Ramanathan L, Ohtsu H, Nishino S, Sakai N, Yamanaka A, Stone C, Cornford M et al..  2013.  Greatly increased numbers of histamine cells in human narcolepsy with cataplexy.. Annals of Neurology. 74(6):786-93.
Hsieh K-C, Nguyen D, Siegel JM, Lai Y-Y.  2013.  New pathways and data on rapid eye movement sleep behaviour disorder in a rat model.. Sleep Med. 14(8):719-28.
2012
Lamkin DM, Sloan EK, Patel AJ, Chiang BS, Pimentel MA, C Y Ma J, Arevalo JM, Morizono K, Cole SW.  2012.  Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling.. Brain Behav Immun. 26(4):635-41.
2011
Wu M-F, Nienhuis R, Maidment N, Lam HA, Siegel JM.  2011.  Role of the hypocretin (orexin) receptor 2 (Hcrt-r2) in the regulation of hypocretin level and cataplexy.. J Neurosci. 31(17):6305-10.
2010
Sood AK, Armaiz-Pena GN, Halder J, Nick AM, Stone RL, Hu W, Carroll AR, Spannuth WA, Deavers MT, Allen JK et al..  2010.  Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis.. J Clin Invest. 120(5):1515-23.
2009
Scammell TE, Willie JT, Guilleminault C, Siegel JM.  2009.  A consensus definition of cataplexy in mouse models of narcolepsy.. Sleep. 32(1):111-6.
2008
Lai Y-Y, Hsieh K-C, Nguyen D, Peever J, Siegel JM.  2008.  Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: an animal model of motor disorders in sleep.. Neuroscience. 154(2):431-43.
Capitanio JP, Abel K, Mendoza SP, Blozis SA, McChesney MB, Cole SW, Mason WA.  2008.  Personality and serotonin transporter genotype interact with social context to affect immunity and viral set-point in simian immunodeficiency virus disease.. Brain Behav Immun. 22(5):676-89.
Cole SW.  2008.  Psychosocial influences on HIV-1 disease progression: neural, endocrine, and virologic mechanisms.. Psychosom Med. 70(5):562-8.
2006
Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M et al..  2006.  Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.. Nat Med. 12(8):939-44.
Gold SM, Irwin MR.  2006.  Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.. Neurol Clin. 24(3):507-19.
2004
John J, Wu M-F, Boehmer LN, Siegel JM.  2004.  Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior.. Neuron. 42(4):619-34.
2000
John J, Wu MF, Siegel JM.  2000.  Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs.. Sleep Res Online. 3(1):23-8.
1996
Reid MS, Tafti M, Nishino S, Sampathkumaran R, Siegel JM, Mignot E.  1996.  Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine.. Brain Res. 733(1):83-100.